# ossiumhealth.com

> AI-optimized mirror of ossiumhealth.com containing 50 pages totalling 22,451 words of clean markdown content, structured data, and semantic HTML. Original source: https://ossiumhealth.com. Last updated: 2026-08-09T02:07:39.095Z.

Each page is available as HTML (with JSON-LD structured data) and Markdown (text-only, ideal for LLMs and RAG).

## Homepage

- [Homepage - Ossium Health](/content/site-root.html) (82 words, Jul 19, 2021)

## Articles & Blog Posts

- [Taylor Lundeen - Ossium Health](/content/people/taylor-lundeen/index.html) (152 words, Aug 4, 2026)
- [Charles Elder - Ossium Health](/content/people/charles-elder/index.html) (12 words, Aug 4, 2026)
- [Forbes Names Ossium Health a 2026 Next Billion-Dollar Startup - Ossium Health](/content/forbes-names-ossium-health-a-2026-next-billion-dollar-startup.html): Recognition highlights the company's organ donor-derived bone marrow bank and its growing clinical impact SAN FRANCISCO--(BUSINESS WIRE)--Ossium Health, a bioengineering company that built the world's first bank of organ donor-derived bone marrow, has been named to the 2026 Forbes Next Billion-Dollar Startups list, Forbes' annual selection of 20 fast-growing U.S. companies it considers most likely to reach (319 words, Jul 29, 2026)
- [First Pediatric Transplant with Ossium Bone Marrow - Ossium Health](/content/first-pediatric-transplant-with-ossium-bone-marrow/index.html): Physicians at Riley Children’s Health at Indiana University (IU) Health have performed the first pediatric bone marrow transplant using Ossium's off-the-shelf bone marrow. This milestone extends a treatment approach that has shown encouraging results in adults and is a meaningful step in expanding donor options for children. The 14-year-old patient was diagnosed with acute myeloid (824 words, Jul 1, 2026)
- [Ossium Health Hosts Facility Tour and Reception for Indiana Governor Mike Braun and Healthcare Leaders - Ossium Health](/content/ossium-health-hosts-facility-tour-and-reception-for-indiana-governor-mike-braun-and-healthcare-leaders.html): Indianapolis Biotech Marks Growing Milestone in the Fight Against Blood Cancer INDIANAPOLIS--(BUSINESS WIRE)--This week, Ossium Health hosted a facility tour and reception at its Indianapolis production facility, bringing together Indiana state officials and healthcare leaders to celebrate the company's pioneering work in cell therapy and its contribution to Indiana's growing biotech economy. Indiana Governor Mike (847 words, Apr 10, 2026)
- [Forbes Selects Ossium as One of America’s Best Startup Employers - Ossium Health](/content/forbes-selects-ossium-as-one-of-americas-best-startup-employers.html): For the second time in three years, Ossium Health has been named to Forbes’ list of America’s Best Startup Employers. This annual list highlights a select group of U.S. startups that demonstrate excellence in employee satisfaction, employer reputation, and organizational growth—criteria that reflect not only business performance, but the strength of a company’s culture and (357 words, Mar 3, 2026)
- [Ossium Health’s Certificates and Licenses - Ossium Health](/content/certificates-and-licenses/index.html): Certificates and Licenses FDA Tissue Establishment Registration AATB certificate CLIA certificate CAP participation certificate State tissue bank registrations and permits: Delaware Tissue Bank Letter Illinois Tissue Bank Registration Maryland Tissue Permit California Tissue Bank License Oregon Registration Letter (78 words, Aug 25, 2025)
- [OssiGraft - Ossium Health](/content/ossigraft/index.html) (161 words, Mar 27, 2024)
- [Consumer Health Data Policy - Ossium Health](/content/consumer-health-data-policy/index.html) (411 words, Mar 8, 2024)
- [Ossium’s HOPE Program - Ossium Health](/content/hope/index.html): Expanded access to our bone marrow product for transplant outside of the clinical study. (314 words, Feb 15, 2024)
- [Visit us at AAOS Booth #4238 - Ossium Health](/content/ossigraft-aaos2024/index.html) (96 words, Jan 16, 2024)
- [First Patient Treated with OssiGraft - Ossium Health](/content/first-patient-treated-with-ossigraft/index.html): Ossium Health announced today that the first patient has been treated with its newly released OssiGraft™ viable bone matrix (VBM) allograft in an ankle surgery. OssiGraft is Ossium’s viable bone matrix allograft, which is intended for use in orthopedic surgery to repair, replace, or reconstruct bone defects. This surgery represents Ossium’s transition from a clinical-stage (75 words, Dec 14, 2023)
- [Healio Article Highlights PRESERVE I Study - Ossium Health](/content/healio-article-highlights-preserve-i-study/index.html): The first-in-human study of Ossium’s bone marrow (PRESERVE I) was recently featured in an article published by Healio, a major medical news source for healthcare professionals. The article includes an interview with Kevin Caldwell, CEO, Co-Founder & President of Ossium Health, and Erin Leckrone, Vice President of Clinical Trials at the National Marrow Donor Program (156 words, Nov 30, 2023)
- [Ossium Health Featured in Nasdaq Live from MarketSite - Ossium Health](/content/ossium-health-featured-in-nasdaq-live-from-marketsite.html): Kevin Caldwell, CEO, Co-Founder & President of Ossium Health, recently sat down for an interview with Nasdaq's Kristina Ayanian at their New York headquarters. In the interview, Kevin explained how Ossium is leveraging its organ donor-derived bone marrow platform to improve the accessibility and quality of leukemia treatments today and develop innovative therapies for organ (89 words, Oct 30, 2023)
- [Ossium Health® and Be The Match® Unveil Partnership to Increase Bone Marrow Transplant Accessibility and Treatment Efficiency - Ossium Health](/content/ossium-health-and-be-the-match-unveil-partnership-to-increase-bone-marrow-transplant-accessibility-and-treatment-efficiency.html): Ossium Health, an innovative bioengineering company, is accelerating its mission to revolutionize the field of bone marrow transplantation through a new partnership with the National Marrow Donor Program (NMDP)/Be The Match, which manages the most diverse registry of blood stem cell donors and cord blood units in the world. This collaboration will enable blood cancer patients to (83 words, Aug 31, 2023)
- [Ossium Health Secures $52M Series C to Expand Bone Marrow Bank, Advance Clinical Trials - Ossium Health](/content/series-c/index.html): Ossium Health, Inc. a bioengineering company developing the world's first bank of on-demand bone marrow, today announced a $52 million Series C funding round. The round was led by CPMG, with participation from Vivo Capital, First Round Capital, Manta Ray Ventures, Alumni Ventures, and Asahi Kasei. The company is improving the health, vitality, and longevity (144 words, Jul 25, 2023)
- [Sebastian Giwa - Ossium Health](/content/sebastian-giwa/index.html): On February 8, 2016, Ossium Health was incorporated in Delaware. From 2016 to 2018, Sebastian Giwa held different roles at Ossium until he submitted a signed letter of resignation to the company’s Board of Directors on October 19, 2018. Since his resignation, Sebastian Giwa has not had any role with Ossium Health in any capacity, (186 words, Jun 21, 2023)
- [Partners - Ossium Health](/content/partners/index.html) (291 words, May 4, 2023)
- [Ossium Health Awarded $3.46M in Funding from the California Institute of Regenerative Medicine (CIRM) to Advance GVHD Program - Ossium Health](/content/ossium-health-cirm-grant/index.html): Ossium Health, Inc. announced today that the California Institute of Regenerative Medicine (CIRM) has awarded the company a $3.46M Clinical Stage Research Program (CLIN1) grant to support the continued clinical development of OSSM-007, Ossium’s interferon-gamma primed mesenchymal stem cell product, for the treatment of steroid-refractory acute graft versus host disease (GVHD). This funding will support (129 words, Apr 28, 2023)
- [RUO Mesenchymal Stem Cells - Ossium Health](/content/ruo-human-mesenchymal-stem-cells/index.html): Product Description Ossium’s RUO MSCs are derived from the vertebral bodies of organ donors and are phenotypically and functionally equivalent to MSCs obtained from aspirated BM. Product Name SKU Quantity RUO Cryopreserved MSCs, Passage 2 INVR-001-1 1 million cell / vial RUO Cryopreserved MSCs, Passage 4 INVR-002-1 1 million cell / vial Characterization The cells (156 words, Mar 1, 2023)
- [RUO Human Selected CD34+ Stem Cells - Ossium Health](/content/human-selected-cd34-stem-cells-ruo/index.html): Product Description Ossium's RUO CD34+ cells are aseptically selected from the bone marrow of vertebral bodies by density gradient and positive immunomagnetic separation. Product Name SKU Quantity RUO Selected CD34+ Cells from HPC, Marrow INVR-003-0.5 500,000 cell / vial RUO Selected CD34+ Cells from HPC, Marrow INVR-003-1 1 million cell / vial RUO Selected CD34+ (142 words, Mar 1, 2023)
- [Human Selected CD34+ Stem Cells (GMP) - Ossium Health](/content/human-selected-cd34-stem-cells-gmp/index.html): Product Description Ossium’s CD34+ cells are aseptically selected from the bone marrow of vertebral bodies by density gradient and positive immunomagnetic separation. The standard GMP vial contains 25M CD34+ cells, though other volumes may be available upon request. Product Name SKU Quantity GMP Selected CD34+ Cells from HPC, Marrow INVC-005-25 25 million cell / vial (159 words, Feb 27, 2023)
- [Terms & Conditions - Ossium Health](/content/ruo-terms-and-conditions/index.html) (4,615 words, Feb 9, 2023)
- [Ossium’s CEO, Kevin Caldwell, featured on BioAge Podcast - Ossium Health](/content/ossiums-ceo-kevin-caldwell-featured-on-bioage-podcast.html): Kevin Caldwell, Ossium's CEO & Co-Founder, was featured on the latest episode of Translating Aging, a podcast produced by BioAge Labs featuring entrepreneurs and scientists who are advancing the science of human longevity and developing therapeutics to extend the human healthspan. In this episode, Kevin speaks with host Chris Patil, PhD, about Ossium’s groundbreaking (142 words, Feb 9, 2023)
- [Publications - Ossium Health](/content/publications/index.html): Hematopoietic stem cells from organ donors lead to long-term multi-lineage engraftment in NSG mice L.M. Breyer, H. Wang, H. Ma, D. Gu, B.H. Johnstone, S. Pan, E.J. Woods, M.Y. MaparaBone Marrow Transplantation, (April 2026) DOI: 10.1038/s41409-026-02864-7 Summary: This study demonstrates that CD34⁺ hematopoietic stem and progenitor cells from deceased organ donors can successfully engraft and (2,319 words, Feb 2, 2023)
- [Careers - Ossium Health](/content/careers/index.html) (670 words, Jan 31, 2023)
- [GMP Human Mesenchymal Stem Cells - Ossium Health](/content/msc-cgmp/index.html): Product Description Ossium's GMP MSCs are derived from the vertebral bodies of organ donors and are phenotypically and functionally equivalent to MSCs obtained from aspirated BM. Product Name SKU Quantity GMP Cryopreserved vBM MSCs, Passage 4 INVC-006-100 100 million cell / vial Characterization The cells express typical MSC surface markers (CD73, CD90, and CD105), lack (175 words, Jan 10, 2023)
- [Ossium Health Jobs - Ossium Health](/content/jd/index.html) (117 words, Jan 5, 2023)
- [Products - Ossium Health](/content/products/index.html) (281 words, Dec 14, 2022)
- [Ossium Health’s First Meeting on the Mesa - Ossium Health](/content/meeting_on_the_mesa/index.html): Kevin Caldwell, Ossium's Co-Founder & CEO, gave a presentation about Ossium and the Promise of Bone Marrow Banking at Meeting on the Mesa, one of the year's biggest biotech conferences that brings together senior executives and top decision-makers in the Cell & Gene therapy industry to share their companies' clinical and commercial progress in the (156 words, Oct 25, 2022)
- [Ossium Celebrates National Donate Life Month - Ossium Health](/content/ossium-health-celebrates-national-donate-life-month.html): The San Francisco (top) and Indianapolis (bottom) Ossium teams wearing their Blue and Green for Donate Life Month This April, Ossium Health continues to be a proud supporter of National Donate Life Month. Founded in 2003 by Donate Life America and its partnering organizations, National Donate Life Month is an opportunity to celebrate those who (760 words, Apr 21, 2022)
- [Ossium Health Announces FDA Clearance of its Investigational New Drug Application for Treatment of Perianal Fistulizing Crohn’s Disease - Ossium Health](/content/ossium-health-announces-fda-clearance-of-its-investigational-new-drug-application-for-treatment-of-perianal-fistulizing-crohns-disease.html): SAN FRANCISCO (March 16, 2022) - Ossium Health, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for OSSM-001, a mesenchymal stem cell (MSC) product, for the treatment of refractory perianal fistulas in patients with Crohn’s disease. Ossium plans to initiate patient screening and enrollment (397 words, Mar 16, 2022)
- [A Letter from Our CEO - Ossium Health](/content/a-letter-from-our-ceo/index.html): Here at Ossium, we publish monthly internal newsletters highlighting company updates and accomplishments. Each newsletter also includes a brief note from our CEO, Kevin Caldwell. In February’s edition, Kevin reflected on all of the progress we made in 2021, despite facing a host of challenges as a company and society. Check out Kevin’s letter below. (507 words, Feb 9, 2022)
- [A Day in the Lab - Ossium Health](/content/a-day-in-the-lab/index.html): As a biotech company, we are in the business of helping people. We go to work with the mission to improve the health, vitality, and longevity of human beings through bioengineering. The individuals who work in our lab embody these values in their daily work making innovative cell therapy products for patients in need. With (625 words, Oct 26, 2021)
- [Battling Blood Cancer at Ossium - Ossium Health](/content/battling-blood-cancer-at-ossium/index.html): September is Blood Cancer Awareness Month, a time to raise awareness about the many ongoing efforts to fight blood cancer and to remember the hundreds of thousands of patients who have passed away due to these devastating conditions. Blood cancer encompasses disorders that affect the blood, bone marrow, and lymphatic system. Depending on the type (376 words, Sep 30, 2021)
- [Our Team - Ossium Health](/content/our-team-2/index.html) (3,225 words, Sep 20, 2021)
- [The Return to the Office in San Francisco - Ossium Health](/content/the-return-to-the-office-in-san-francisco/index.html): Since the beginning of the pandemic, our facility in Indianapolis has had business-critical employees onsite to keep our production and manufacturing operations running smoothly. As a science-based company, we have followed the latest data-backed policies and advisories of the CDC and local governments. We are proud of our team in Indianapolis for staying safe and (499 words, Sep 15, 2021)
- [LifeGift and Ossium Health Offer Hope with Bone Marrow Clinical Application - Ossium Health](/content/lifegift-and-ossium-health/index.html): (Houston – July 26, 2021) – LifeGift, the organ procurement organization (OPO) facilitating organ and tissue donation in Southeast, West, and North Texas, and Ossium Health, a therapeutics company harnessing the power of stem cell science to improve treatment for patients with blood and immune diseases, are proud to announce a collaborative partnership. In 2017, LifeGift (589 words, Jul 27, 2021)
- [Scaling a World-Class Team in 2021 - Ossium Health](/content/scaling-a-world-class-team-in-2021/index.html): Here at Ossium, we know that hiring the right people is the most important part of building a great team, so we are very happy to announce that we have welcomed more than 35 new all-star employees over the past 6 months. We have more than doubled in size and now have almost 70 employees (223 words, Jul 21, 2021)
- [Newsroom - Ossium Health](/content/newsroom/index.html) (115 words, Jul 19, 2021)
- [Company About - Ossium Health](/content/company/index.html) (528 words, Jun 30, 2021)
- [Platform - Ossium Health](/content/platform/index.html) (166 words, Jun 30, 2021)
- [Excellthera and Ossium Health Announce a Collaboration to Advance Their Technologies and Platforms to Improve Human Health - Ossium Health](/content/excellthera-and-ossium-health-announce-a-collaboration-to-advance-their-technologies-and-platforms-to-improve-human-health.html): ExCellThera Inc., a clinical-stage cell and molecular medicine company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, and Ossium Health, a therapeutics company harnessing the power of stem cell science to improve treatment for patients with blood and immune diseases, announced on April 21 a collaboration agreement to evaluate (134 words, Apr 21, 2021)
- [Ossium Health and Columbia University Irving Medical Center Initiate Phase 1 Study Using Bone Marrow Stem Cells to Minimize Immunosuppression Requirements in Intestinal Transplantation - Ossium Health](/content/ossium-health-and-columbia-university-irving-medical-center-initiate-phase-1-study-using-bone-marrow-stem-cells-to-minimize-immunosuppression-requirements-in-intestinal-transplantation.html): Intestinal transplantation is lifesaving for patients with injury or disease of the intestines, but surgical success is hampered by high rejection rates resulting from an immune attack of the recipient against the donor, termed host-vs-graft reactivity. The high levels of immunosuppression historically required to prevent rejection drive elevated risk of infections and cancer. Ossium and (280 words, Apr 15, 2021)
- [Ossium CEO, Kevin Caldwell, featured on Flux podcast - Ossium Health](/content/ossium-ceo-featured-on-flux-podcast/index.html): Kevin Caldwell, Ossium's Co-Founder & CEO, was featured on the latest podcast from Flux. Kevin chats with Flux's Alice Lloyd George about Ossium's mission, the history of bone marrow transplants, and the future of medicine. (35 words, Dec 12, 2020)
- [Venture Stories Podcast with Co-Founder, President & CEO, Kevin Caldwell - Ossium Health](/content/venture-stories-podcast-with-co-founder-president-ceo-kevin-caldwell.html): Co-Founder, President & CEO, Kevin Caldwell talks about the mission and inspiration of Ossium Health in a recent Venture Stories podcast hosted by Village Global. Listen here! (27 words, May 13, 2020)
- [3D Heals Podcast with Co-Founder, President & CEO, Kevin Caldwell - Ossium Health](/content/3d-heals-podcast-with-co-founder-president-ceo-kevin-caldwell.html): 3DHEALS invites technological game-changers, entrepreneurs, venture capitalists, world-class clinicians, scientists, and other expert stakeholders to have deep-dive conversations on how to re-invent healthcare using 3D printing, bioprinting, and related emerging technologies. Dr. Jenny Chen speaks with our Co-Founder, President, and CEO, Kevin Caldwell, about Kevin's personal journey as an entrepreneur, how such a bone marrow/stem (86 words, Apr 28, 2020)
- [Ossium Awarded Phase I Grant from NIH - Ossium Health](/content/ossium-wins-phase-i-grant-from-national-institute-of-health.html): The National Institutes of Health notified Ossium that its proposal to demonstrate that the pool of viable, deceased donors for bone marrow transplants includes tissue donors -- deceased donors who do not satisfy all of the health requirements of organ donors -- is likely to be accepted. The NIH's decision to support Ossium's research could (87 words, Dec 30, 2016)
- [First Round Capital Backs Ossium - Ossium Health](/content/first-round-capital-backs-ossium/index.html): Leading venture capital firm First Round Capital -- early investors in Uber, Square, Flatiron Health and more than 250 other companies -- has backed Ossium Health. The San Francisco, New York, and Philadelphia based VC specializes in early stage companies, pairing its "seed investments" with a suite of company-building services for its portfolio companies. (54 words, Aug 18, 2016)

## Resources

- [Full Page Index](/index.html): Browse all cached pages with rich metadata
- [About This Cache](/about.html): Methodology, technical details, and usage guidelines
- [XML Sitemap](/sitemap.xml): Machine-readable sitemap for crawler discovery
- [Robots.txt](/robots.txt): Crawler directives